ALTERA Usb blasterPL-USB-BLASTER-RCNALTERA Usb blaster 下載電纜 主要特性:• 支持1.8伏,2.5伏, 3.3伏和5.0伏系統(tǒng) • 支持SignalTap II 邏輯分析儀 • 支持EPCS串行配置器件的主動串行配置模式 • 支持和Nios II嵌入式處理器系列 的通訊和調(diào)試 詳細特性介紹:
1.支持1.8V, 2.5V、3.3V 和5.0V 應用系統(tǒng).2.支持SignalTap II 嵌入式邏輯分析儀功能.3.支持ALTERA 公司全系列器件 CPLD:MAX3000、MAX7000、MAX9000 和MAX II 等 FPGA:Stratix、Stratix II、Cyclone、Cyclone II、ACEX 1K、APEX 20K 和FLEX 10K等 主動串行配置器件:EPCS1、EPCS4、EPCS16等 增強配置器件:EPC1、EPC4 等。
目前已經(jīng)測試過的芯片有 Cyclone-------EP1C3、EP1C6、EP1C12、EP1C20, Cyclone II----EP2C8、EP2C35,EP2C20,EP2C70 FLEX10K------EPF10K10、EPF0K30 ACEX1K-------EP1K30 MAX7000-----MAX7128SLC84、MAX7128AETC100 MAX3000-----MAX3128 EPCS----------EPCS1、EPCS4、EPCS16 EPC------------EPC1、EPC44.支持NIOS調(diào)試,支持NIOS下的FLASH燒寫.
5.支持三種下載模式(AS、PS和JTAG) 測試上面的芯片時,采用了三種不同的編程模式 JTAG 下載模式。篊yclone、Cyclone II、Stratix II、Flex10K、Acex1K、Max7000 和Max3000 測試時采用 主動串行(AS)模式:EPCS1 和EPCS4、EPCS16 被動串行(PS)模式:Stratix 和Stratix GX測試時采用6.速度快,性能穩(wěn)定. 下載FPGA 配置程序是ByteblasterII 的6 倍。在一些速度要求高的應用場合下仍可使用SignalTap II 嵌入式邏輯分析儀進行實時分析。調(diào)試Nios II處理器時同樣可以處理一些實時應用. 7.使用方便, 只有要USB 口的計算機都能使用USB-Blaster。不象ByteblasterII 那樣要求計算機帶有并口! 目前許多筆記本電腦,甚至臺式機都不再配備并口,此時ByteblasterII 將無法使用
由于公司網(wǎng)店和實體店同時進行銷售,終價格和庫存數(shù)量請和銷售人員落實后再購買,請廣大買家諒解!其他購買問題們會耐心為您解答。
產(chǎn)品簡介:
※ 12位DA精度※ 模擬量輸出通道:4路※ 輸出頻率1MS/s※ DA緩存:每路256K字RAM※ DA量程:±10V,±5V
鴻研電子提供的產(chǎn)品如下:
電腦平臺類:
工控機、嵌入式無風扇計算機、加固工控機、工業(yè)平板電腦、工業(yè)顯示器、
一體機、工業(yè)服務器、HMI人機界面、觸摸屏
采集與控制類:
可編程控制器(PLC、PAC)、變頻器、多功能數(shù)據(jù)采集卡(DAQ) 、運動控制卡、數(shù)字量 IO 卡、遠程 IO模塊
工業(yè)通訊類:
工業(yè)以太網(wǎng)交換機、串口聯(lián)網(wǎng)服務器、現(xiàn)在總線網(wǎng)關(guān)、工業(yè)多串口卡
接口轉(zhuǎn)換器(RS232 轉(zhuǎn) RS422/485、光電轉(zhuǎn)換、串口轉(zhuǎn)光纖、USB 轉(zhuǎn)串口、中繼器、集線器、USB HUB)
工業(yè)無線產(chǎn)品(無線串口服務器、無線 AP、無線接入控制、IP網(wǎng)關(guān)、工業(yè) GSM/GPRS 路由器)
軟件類: Windows 正版系統(tǒng)、組態(tài)軟件、可根據(jù)客戶需求定制開發(fā)機器視覺,運動控制,采集等軟件
合作品牌商:
臺灣系:研華、摩莎、泓格、臺達
大陸系:阿爾泰、宇泰
日美系:西門子、三菱、歐姆龍
產(chǎn)品詳細說明 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
精密天平,精密電子天平:
賽多利斯型CP系列是的實驗室專業(yè)天平。憑借獨創(chuàng)、的設計理念、的造型和高超的機電技術(shù),CP創(chuàng)造了實驗室稱量的新標準。0.001mg-34kg 的25種型號,為實驗室稱量工作提供了高質(zhì)量的產(chǎn)品,具有的價格/性能比。 | ||
CP型號標準配置具有以下的特性: | ||
● 有背景光的液晶顯示屏(CP2P、CP2P-F、CP225D型號沒有背景光),字體高度:16.5mm 0.001g精密天平防風罩的側(cè)面玻璃板可取出,上蓋與防風罩的一邊相連,可以翻啟 ● 精度0.01mg/0.1mg的天平有全玻璃防風罩 ● 雙向數(shù)據(jù)接口RS232 ● 內(nèi)置全自動校準砝碼(微量/準微量/分析天平) ● 只需按一個鍵,就可以使用外校砝碼進行全自動校準和調(diào)整(所有精密天平) ● 天平下部吊鉤稱量(造型5是選件)● 超載保護 符合 ISO/GLP 的記錄和打印功能(連接賽多利斯 YDP03-OCE 或 PC 機)● 應用程序:百分比稱量,凈重/總和配方計算,動態(tài)稱量/動物稱重,單位換算,計數(shù) ● 適應外部環(huán)境的數(shù)字濾波器 水平支腳、水平儀、防盜環(huán)(8.2kg以下的天平) ● 左、右去皮鍵滿足不同的使用習慣 ● 觸感反饋式按鍵 ● 防靜電涂層玻璃防風罩,能地屏蔽外界靜電荷的干擾● 40M超高速微處理器MC1 | ||
|
|
選用用Microchip公司新一代CAN控制器,符合CAN Ver2.0B標準,總線通訊速率為1Mbit/s。CAN收發(fā)器采用Philips公司PCA82C250,并于CAN控制器之間采用6N137高速光藕。整板電路設計簡潔,。與主機之間采用SPI高速通訊,已應用與多種工業(yè)控制產(chǎn)品。CAN接口:單通道CAN2.0B(可擴展到雙通道)主機接口:SPI,通訊速率10Mbit/s功耗:<50mA供電:3.3V(控制器)/5V(收發(fā)器)
A-1421-2 | Amyloid β-Protein (1-40) (mouse, rat) | C190H291N51O57S | 4233.78 | 144409-98-3 | H-Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-3 | (Arg3)-Amyloid β-Protein (1-40) Amyloid β-Protein (1-40) E3R | C195H300N56O56S | 4356.94 | H-Asp-Ala-Arg-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1421-4 | (Asn(4-aminobutyl)1·7·23,Gln(4-aminobutyl)3·11·22)-Amyloid β-Protein (1-40) (Asp(4-aminobutylamide)1·7·23,Glu(4-aminobutylamide)3·11·22)-Amyloid β-Protein (1-40) | C218H355N65O52S | 4750.69 | H-Asn(4-aminobutyl)-Ala-Gln(4-aminobutyl)-Phe-Arg-His-Asn(4-aminobutyl)-Ser-Gly-Tyr-Gln(4-aminobutyl)-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gln(4-aminobutyl)-Asn(4-aminobutyl)-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1421-5 | Biotinyl-Amyloid β-Protein (1-40) | C204H309N55O60S2 | 4556.16 | 183906-14-1 | Biotinyl-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-6 | (7-Diethylaminocoumarin-3-yl)carbonyl-Amyloid β-Protein (1-40), DAC-Amyloid ß-Protein (1-40) | C208H308N54O61S | 4573.13 | (7-Diethylaminocoumarin-3-yl)carbonyl-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1421-7 | FITC-β-Ala-Amyloid β-Protein (1-40) | C218H311N55O64S2 | 4790.33 | FITC-β-Ala-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1421-8 | (Gln9)-Amyloid β-Protein (1-40) Amyloid β-Protein (1-40) G9Q | C197H300N54O59S | 4400.94 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gln-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1421-9 | (Gln22)-Amyloid β-Protein (1-40) Amyloid β-Protein (1-40) Dutch Mutation, Amyloid β-Protein (1-40) E22Q | C194H296N54O57S | 4328.88 | 144410-00-4 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-10 | (Gly21)-Amyloid β-Protein (1-40) Amyloid β-Protein (1-40) Flemish Mutation, Amyloid β-Protein (1-40) A21G | C193H293N53O58S | 4315.84 | 154362-03-5 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Gly-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-11 | (Gly22)-Amyloid β-Protein (1-40) Amyloid β-Protein (1-40) Arctic Mutation, Amyloid β-Protein (1-40) E22G | C191H291N53O56S | 4257.80 | 175010-18-1 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-12 | (Lys22)-Amyloid β-Protein (1-40) Amyloid β-Protein (1-40) Italian Mutation, Amyloid β-Protein (1-40) E22K | C195H300N54O56S | 4328.92 | 302905-01-7 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Lys-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-13 | (Arg6)-Amyloid β-Protein (1-40), Amyloid β-Protein (1-40) English Mutation, Amyloid β-Protein (1-40) H6R | C194H300N54O58S | 4348.91 | H-Asp-Ala-Glu-Phe-Arg-Arg-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1421-14 | (Asn7)-Amyloid β-Protein (1-40), Amyloid β-Protein (1-40) Tottori Mutation, Amyloid β-Protein (1-40) D7N | C194H296N54O57S | 4328.88 | H-Asp-Ala-Glu-Phe-Arg-His-Asn-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1421-15 | (Asn23)-Amyloid β-Protein (1-40), Amyloid β-Protein (1-40) Iowa Mutation, Amyloid β-Protein (1-40) D23N, Abeta (1-40) D23N | C194H296N54O57S | 4328.88 | 374796-72-2 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asn-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-16 | (Cys0)-Amyloid β-Protein (1-40) | C197H300N54O59S2 | 4433.01 | 208266-35-7 | H-Cys-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1421-17 | (Nle35)-Amyloid β-Protein (1-40) | C195H297N53O58 | 4311.83 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Nle-Val-Gly-Gly-Val-Val-OH | |
A-1423 | Amyloid β-Protein (1-42) | C203H311N55O60S | 4514.10 | 107761-42-2 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH |
A-1424 | Amyloid β-Protein (42-1) | C203H311N55O60S | 4514.10 | 317366-82-8 | H-Ala-Ile-Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp-OH |
A-1423-2 | Amyloid β-Protein (1-42) (mouse, rat) | C199H307N53O59S | 4418.01 | 166090-74-0 | H-Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH |
A-1423-3 | (Arg17)-Amyloid β-Protein (1-42) | C203H312N58O60S | 4557.13 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Arg-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-4 | (D-Asp1)-Amyloid β-Protein (1-42) | C203H311N55O60S | 4514.10 | H-D-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-5 | Biotinyl-Amyloid β-Protein (1-42) | C213H325N57O62S2 | 4740.40 | Biotinyl-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-6 | Cys-Gly-Lys-Arg-Amyloid β-Protein (1-42) (Cys668,Gly669,Arg671)-Amyloid β/A4 Protein Precursor770 (668-713), (Cys668,Gly669,Arg671)-APP770 (668-713) | C220H343N63O64S2 | 4958.66 | H-Cys-Gly-Lys-Arg-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-7 | ent-Amyloid β-Protein (1-42) | C203H311N55O60S | 4514.10 | 342896-25-7 | H-D-Asp-D-Ala-D-Glu-D-Phe-D-Arg-D-His-D-Asp-D-Ser-Gly-D-Tyr-D-Glu-D-Val-D-His-D-His-D-Gln-D-Lys-D-Leu-D-Val-D-Phe-D-Phe-D-Ala-D-Glu-D-Asp-D-Val-Gly-D-Ser-D-Asn-D-Lys-Gly-D-Ala-D-Ile-D-Ile-Gly-D-Leu-D-Met-D-Val-Gly-Gly-D-Val-D-Val-D-Ile-D-Ala-OH |
A-1423-8 | FITC-β-Ala-Amyloid β-Protein (1-42) | C227H327N57O66S2 | 4974.57 | FITC-β-Ala-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-9 | (Glu20)-Amyloid β-Protein (1-42) Amyloid β-Protein (1-42) F20E | C199H309N55O62S | 4496.04 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Glu-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-10 | (Gly22)-Amyloid β-Protein (1-42) Amyloid β-Protein (1-42) Arctic Mutation, Amyloid β-Protein (1-42) E22G | C200H307N55O58S | 4442.04 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-11 | (Met(O)35)-Amyloid β-Protein (1-42) Amyloid β-Protein (1-42) sulfoxide | C203H311N55O61S | 4530.10 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met(O)-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1423-12 | (Met(O2)35)-Amyloid β-Protein (1-42), Amyloid β-Protein (1-42) sulfone | C203H311N55O62S | 4546.10 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met(O2)-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1425 | Amyloid β-Protein (1-43) | C207H318N56O62S | 4615.21 | 134500-80-4 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-OH |
A-1426 | (Pyr3)-Amyloid β-Protein (3-42) | C196H299N53O55S | 4309.92 | 183449-57-2 | Pyr-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH |
A-1427 | Amyloid β-Protein (6-20) | C86H119N23O23 | 1843.03 | 183745-82-6 | H-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-OH |
A-1428 | Amyloid β-Protein (10-20) | C71H99N17O16 | 1446.67 | 152286-31-2 | H-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-OH |
A-1429 | Amyloid β-Protein (10-35) | C133H204N34O37S | 2903.36 | 237753-66-1 | H-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH |
A-1430 | (Pyr11)-Amyloid β-Protein (11-40) | C143H226N38O39S | 3133.67 | 192377-94-9 | Pyr-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1431 | Amyloid β-Protein (12-28) Alzheimer's Disease β-Protein (12-28) | C89H135N25O25 | 1955.20 | 107015-83-8 | H-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-OH |
A-1432 | Amyloid β-Protein (1-46) | C223H347N59O65S | 4926.63 | 285554-31-6 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-Val-Ile-Val-OH |
A-1433 | Acetyl-Amyloid β-Protein (15-20) amide | C42H63N9O8 | 822.02 | 189064-06-0 | Ac-Gln-Lys-Leu-Val-Phe-Phe-NH2 |
A-1434 | (Lys15)-Amyloid β-Protein (15-21) | C44H69N9O8 | 852.09 | 190775-14-5 | H-Lys-Lys-Leu-Val-Phe-Phe-Ala-OH |
A-1435 | (Arg15,Asp16·25,Pro18·21·23,Val22,Ile24)-Amyloid β-Protein (15-25) | C64H94N14O16 | 1315.54 | 182912-63-6 | H-Arg-Asp-Leu-Pro-Phe-Phe-Pro-Val-Pro-Ile-Asp-OH |
A-1435-2 | Gly-Amyloid β-Protein (15-25)-Gly-ε-aminocaproyl(-Lys)6 H-Gly-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Gly-εAhx-Lys-Lys-Lys-Lys-Lys-Lys-OH | C105H178N28O26 | 2248.74 | 184951-46-0 | H-Gly-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Gly-ε-aminocaproyl-Lys-Lys-Lys-Lys-Lys-Lys-OH |
A-1436-2 | ent-[Amyloid β-Protein (20-16)]-β-Ala-D-Lys(ent-[Amyloid β-Protein (16-20)]) ent-[retro-Amyloid β-Protein (16-20)]-β-Ala-D-Lys(ent-[Amyloid β-Protein (16-20)]), (ffvlk)2(βA)k (tandem dimer) | C79H119N15O13 | 1486.91 | H-D-Phe-D-Phe-D-Val-D-Leu-D-Lys-β-Ala-D-Lys(D-Lys-D-Leu-D-Val-D-Phe-D-Phe-H)-OH | |
A-1436 | Amyloid β-Protein (16-20) | C35H52N6O6 | 652.84 | 153247-40-6 | H-Lys-Leu-Val-Phe-Phe-OH |
A-1437 | (Pro18,Asp21)-Amyloid β-Protein (17-21) | C33H43N5O8 | 637.73 | 182912-74-9 | H-Leu-Pro-Phe-Phe-Asp-OH |
A-1437-2 | Acetyl-(Pro18,Asp21)-Amyloid β-Protein (17-21) amide Ac-LPFFD-NH2 | C35H46N6O8 | 678.79 | 339990-02-2 | Ac-Leu-Pro-Phe-Phe-Asp-NH2 |
A-1437-3 | Amyloid β-Protein (20-29) | C43H66N12O17 | 1023.07 | 311818-43-6 | H-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-OH |
A-1438 | Amyloid β-Protein (22-35) | C59H102N16O21S | 1403.62 | 144189-71-9 | H-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH |
A-1439 | Amyloid β-Protein (25-35) | C45H81N13O14S | 1060.28 | 131602-53-4 | H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-OH |
A-1439-2 | (Met(O)35)-Amyloid β-Protein (25-35) | C45H81N13O15S | 1076.28 | 292147-12-7 | H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met(O)-OH |
A-1439-4 | (Nle35)-Amyloid β-Protein (25-35) | C46H83N13O14 | 1042.24 | 163265-32-5 | H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Nle-OH |
A-1440 | Amyloid β-Protein (35-25) | C45H81N13O14S | 1060.28 | 147740-73-6 | H-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-OH |
A-1439-3 | Amyloid β-Protein (25-35) amide | C45H82N14O13S | 1059.30 | 147490-49-1 | H-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-NH2 |
A-1441 | Amyloid β-Protein (29-40) | C49H88N12O13S | 1085.38 | 184865-04-1 | H-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH |
A-1442 | Propionyl-Amyloid β-Protein (31-34) amide | C23H43N5O5 | 469.63 | 256419-86-0 | Propionyl-Ile-Ile-Gly-Leu-NH2 |
A-1443 | Amyloid β-Protein (31-35) | C25H47N5O6S | 545.74 | 149385-65-9 | H-Ile-Ile-Gly-Leu-Met-OH |
A-1445-2 | Cys-Gly-His-Gly-Asn-Lys-Ser-Amyloid β-Protein (33-40) | C58H99N19O18S2 | 1414.67 | H-Cys-Gly-His-Gly-Asn-Lys-Ser-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1445 | Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (33-40) | C51H93N15O14S2 | 1204.52 | H-Cys-Gly-Lys-Lys-Gly-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH | |
A-1446 | Amyloid β-Protein (33-42) Amyloid β/A4 Protein Precursor770 (704-713), APP770 (704-713) | C41H74N10O11S | 915.17 | 178949-81-0 | H-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-OH |
A-1447 | Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (35-40) | C43H79N13O12S2 | 1034.31 | H-Cys-Gly-Lys-Lys-Gly-Met-Val-Gly-Gly-Val-Val-OH | |
A-1444 | Cys-Gly-Lys-Lys-Gly-Amyloid β-Protein (36-42) | C47H86N14O13S | 1087.35 | H-Cys-Gly-Lys-Lys-Gly-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1448 | Non-Aβ Component of Alzheimer's Disease Amyloid NAC | C141H235N39O49 | 3260.65 | 154040-19-4 | H-Glu-Gln-Val-Thr-Asn-Val-Gly-Gly-Ala-Val-Val-Thr-Gly-Val-Thr-Ala-Val-Ala-Gln-Lys-Thr-Val-Glu-Gly-Ala-Gly-Ser-Ile-Ala-Ala-Ala-Thr-Gly-Phe-Val-OH |
A-1449 | Amyloid β-Protein (1-14) | C73H99N23O25 | 1698.73 | 186319-74-4 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-OH |
A-1450 | Amyloid ß-Protein (37-39) | C9H17N3O4 | 231.25 | 20274-89-9 | H-Gly-Gly-Val-OH |
A-1451 | (Leu16)-Amyloid β-Protein (16-19) | C26H42N4O5 | 490.64 | 24205-68-3 | H-Leu-Leu-Val-Phe-OH |
A-1452 | (Nle35)-Amyloid β-Protein (1-42) | C204H313N55O60 | 4496.06 | H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Nle-Val-Gly-Gly-Val-Val-Ile-Ala-OH | |
A-1453 | Methoxysuccinyl-Amyloid β-Protein (39-42)-p-nitroanilide | C30H46N6O9 | 634.73 | MeOSuc-Val-Val-Ile-Ala-pNA | |
A-1454 | Amyloid β-Protein (38-40) | C9H17N3O4 | 231.25 | 21835-35-8 | H-Val-Gly-Gly-OH |
A-1502 | Angiogenin (108-122) | C78H125N25O23 | 1781.01 | 112173-49-6 | H-Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg-OH |
A-1503 | Angiogenin (108-123) | C83H132N26O24 | 1878.12 | 112173-48-5 | H-Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg-Pro-OH |
A-1601 | Angiotensin A Ala-Angiotensin III, (Ala1)-Angiotensin II | C49H71N13O10 | 1002.18 | 51833-76-2 | H-Ala-Arg-Val-Tyr-Ile-His-Pro-Phe-OH |
A-1602 | Angiotensin I Ang I, Angiotensinogen (1-10) | C62H89N17O14 | 1296.50 | 484-42-4 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH |
A-1602-2 | Acetyl-Angiotensin I | C64H91N17O15 | 1338.53 | 67509-13-1 | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH |
A-1602-3 | Biotinyl-Angiotensin I | C72H103N19O16S | 1522.79 | Biotinyl-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH | |
A-1602-4 | (Des-Asp1)-Angiotensin I | C58H84N16O11 | 1181.41 | 56317-01-2 | H-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-OH |
A-1602-5 | (Val5,Asn9)-Angiotensin I Angiotensin I (bullfrog) | C59H86N16O15 | 1259.43 | H-Asp-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu-OH | |
A-1603 | Angiotensin I (1-9) | C56H78N16O13 | 1183.34 | 34273-12-6 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-OH |
A-1604 | Angiotensin (1-12) (human) Angiotensinogen (1-12) (human), Proangiotensin-12 (human) | C73H109N19O16 | 1508.79 | 136865-09-3 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-OH |
A-1604-2 | Angiotensin (1-12) (mouse, rat) Angiotensinogen (1-12) (mouse, rat), Proangiotensin (1-12) (mouse, rat) | C77H109N19O17 | 1572.83 | 914910-73-9 | H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Tyr-OH |
上海仁彩自動化科技有限公司
聯(lián)系人:徐生波(銷售經(jīng)理)
手 機:13817238655 15001934687
Q Q:2873364134
傳 真:
地 址:上海市金山區(qū)楓涇鎮(zhèn)新涇路59號電氣數(shù)據(jù) | |
單位長度阻尼量 | |
| 0.0025 dB/m |
| 0.0040 dB/m |
| 0.022 dB/m |
| 0.042 dB/m |
波阻 | |
| 150 Ω |
| 270 Ω |
| 185 Ω |
| 150 Ω |
相對對稱公差 | |
| 10 % |
| 10 % |
| 10 % |
單位長度的回路電阻 / 最大值 | 110 Ω/km |
單位長度的屏蔽電阻 / 最大值 | 9.5 Ω/km |
每一長度的容量 / 在1 kHz時 | 28.5 pF/m |
工作電壓 | |
| 100 V |
機械數(shù)據(jù) | |
電線數(shù)量 | 2 |
屏蔽層規(guī)格 | 重疊的鋁膠合箔,包裹鍍錫銅線制成的屏蔽編織層 |
FastConnect | 是 |
外徑 | |
| 0.65 mm |
| 2.55 mm |
| 5.4 mm |
| 8 mm |
外徑的對稱公差 / 電纜護套 | 0.4 mm |
材料 | |
| PE |
| PVC |
| PVC |
顏色 | |
| 紅色 / 綠色 |
| 紫色 |
彎曲半徑 | |
| 37.5 mm |
| 75 mm |
拉力負荷 / 最大值 | 100 N |
單位長度重量 | 80 kg/km |
許可的環(huán)境條件 | |
安裝時 | |
| -40…+75 °C |
| -40…+75 °C |
| -40…+75 °C |
| -40…+75 °C |
| 20 Cel 時測量電氣屬性,根據(jù) DIN 47250 第 4 部分或 DIN VDE 0472 進行檢查 |
耐化學性 | |
| 耐抗力受條件影響 |
| 耐抗力受條件影響 |
放射折射性 / 抵抗 UV 射線 | 耐抗力 |
產(chǎn)品特點、功能、組件 / 概述 | |
產(chǎn)品特點/不含硅 | |
| 否 |
是 | |
標準、規(guī)范、許可 | |
UL/ETL 列表 / 300 V 評級中 | 是:c(UL)us, CMG / CL3 / Sun Res |
資格證明 | |
| 是 |
| 是 |
| 是 |
船級社 | |
| 否 |
| 否 |
| 否 |
| 否 |
| 否 |
否 | |
| 否 |
SIMATIC NET, PROFIBUS 快速標準電纜 GP, 2 芯, 屏蔽, 為快速安裝而特殊設計,最大長度: 1000m, 最小訂購數(shù)量: 20m, 按米銷售
6XV1830-0EH10 西門子DP總線,PROFIBUS通訊電纜
概述
6XV1830-0EH10
SIMATIC NET, PROFIBUS 快速標準電纜 GP, 2 芯, 屏蔽, 為快速安裝而特殊設計,最大長度: 1000m, 最小訂購數(shù)量: 20m, 按米銷售
Overview
■用于不同應用區(qū)域的不同類型(例如,地下電纜,拖曳電纜,危險區(qū)域(Zone 1 和 Zone 2)) ■雙層屏蔽,抗干擾性能好 ■阻燃總線連接電纜(不含鹵素)。 ■由于電纜上印有以米表示的長度標記,因此易于確定長度 ■UL 認證
PROFIBUS雙芯屏蔽電纜商品信息
![]() | 6GK1905-0EA10 SIMATIC NET,PB FC M12 PLUG PRO M12 插頭式連接器,帶有堅固金屬外殼和 FC 連接方法,帶軸向電纜出口,和 ET200PRO 共用,插針連接器(B 編碼),每包 5 件 | ||
![]() | 6GK1905-0EB10 SIMATIC NET,PB FC M12 PLUG PRO M12 插頭式連接器,帶有堅固金屬外殼和 FC 連接方法,帶軸向電纜出口,和 ET200PRO 共用,插針連接器(B 編碼),每包 5 件 | ||
![]() | 6GK1905-6AA00 SIMATIC NET, PROFIBUS FastConnect 剝線工具, 用于 PROFIBUS FastConnect 總線電纜的快速剝線 | ||
![]() | 6GK1905-6AB00 SIMATIC NET, PROFIBUS FastConnect 刀片盒, 剝線工具備用刀片盒,共 5片 | ||
![]() | 6XV1830-0EH10 SIMATIC NET, PROFIBUS 快速標準電纜 GP, 2 芯, 屏蔽, 為快速安裝而特殊設計,最大長度: 1000m, 最小訂購數(shù)量: 20m, 按米銷售 | ||
![]() | 6XV1830-0EN20 SIMATIC NET, PROFIBUS 標準總線電纜, 2 芯, 屏蔽, 為快速安裝而特殊設計, 20 m | ||
![]() | 6XV1830-0EN50 SIMATIC NET, PROFIBUS 標準總線電纜, 2 芯, 屏蔽, 為快速安裝而特殊設計, 50 m | ||
![]() | 6XV1830-0ET10 SIMATIC NET, PROFIBUS 標準總線電纜, 2 芯, 屏蔽, 為快速安裝而特殊設計, 100m | ||
![]() | 6XV1830-0ET20 SIMATIC NET, PROFIBUS 標準總線電纜, 2 芯, 屏蔽, 為快速安裝而特殊設計, 200 m | ||
![]() | 6XV1830-0ET50 SIMATIC NET, PROFIBUS 標準總線電纜, 2 芯, 屏蔽, 為快速安裝而特殊設計, 500 m |
網(wǎng)卡及電纜 6es7 972-0cb20-0xa0 usb接口編程適配器(usb接口編程電纜) 6es7 972-0cb35-0xa0 ts適配器ii 用于調(diào)制解調(diào)器遠程服務 6es7 972-0cc35-0xa0 ts適配器ii 用于isdn 遠程服務 6gk1 561-1aa01 cp5611網(wǎng)卡(pci總線軟卡,支持mpi,ppi,profibus-dp) 6gk1 551-2aa00 cp5512網(wǎng)卡(pcmcia總線軟卡,支持mpi,ppi,profibus-dp,筆記6xv1 820-5bh50 光纖電纜 含bfoc (5米) 6xv1 820-5bt10 光纖電纜 含bfoc (100米) 6gk1 901-0da20-0aa0 bfoc接頭(每包20只) 6es7 901-0bf00-0aa0 5米mpi電纜 6es7 901-1bf00-0xa0 rs232電纜 6es7 195-7hf80-0xa0 dp/pa耦合器有源總線單元 6gk1 905-0aa00 splitconnect分接頭(10件) 6gk1 905-0ad00 splitconnect終端(ex)(5件) 6gk1 905-0ab10 splitconnect m12輸出端(5件) 6gk1 905-0ac00 splitconnect 耦合器(10件)
Aquarius雙光束紫外分光光度計
強大內(nèi)部控制:Aquarius雙光束紫外分光光度計計算系統(tǒng)含強大軟件,操作迅速,容易使用。標準軟件非
常,需要時可隨時通過E-SEF擴充,裝入額外的軟件模塊。 雙光束光學系統(tǒng):Aquarius雙光束紫外
分光光度計是一種對稱的雙光束系統(tǒng),測量十分,時間穩(wěn)定性高。樣品和基準光束具有同樣的抽
樣空間和設備,可滿足廣泛的實驗要求,不只限于基準光束中的單樣品池。食品專用分光光度計用于食品、飲料分析的DietQuest: Cecil儀器中有三種預先編程的DietQuest分光光度計,用于食品
、飲料分析。方法包括單、多波長測量和光譜掃描。水分析專用分光光度計用于水分析:AquaQuest 4000系列分光光度計是一種專門設計用來滿足水分析分光光度計要求的儀器,有
可見光和紫外兩種多功能性,AquaQuest 4000系列儀器具備所需要的靈活性和性能,它們可進行波長掃描
、樣品池程序設計、分批取樣、波長程序設計、時間線圖表以及反應動力學。生物分析專用分光光度計 BioQuest: 設計小巧,1.8nm光學帶寬,生物分析程序化,為一種功能強大的通用雙光束掃描分光光度
計生物分光光度計:除生物分析和分子生物功能已預先程序化外,BioQuest和BioAquarius還具有紫外可
見分光光度計的一切正常功能,如掃描、時間線圖表、吸光率、單波長測量濃度或可見度、樣品池、波長
程序化、方法保存等。蛋白質(zhì)分析核酸分析;濃度曲線符合的標準:反應動力學:小樣品測量方法生成與
保存:數(shù)據(jù)流-數(shù)據(jù)到微機。藥物溶解專用分光光度計該系統(tǒng)由幾部分來構(gòu)成:溶解測試機,溶解測試軟件,相對應的分光光度計蠕動泵,以及相關(guān)選配件構(gòu)成
FreeForm Plus觸覺式設計軟件
FreeForm Modeling Plus電腦雕刻筆觸覺式設計軟件是源自于1990年美國麻省理工學院(MIT)的研究項目,SensAble Technologies公司將3D Touch的技術(shù)應用到計算機內(nèi),為人類使用計算機起了重大的改變,具有3D力回饋系統(tǒng)(3D force-feedback systems)的FreeForm Modeling Plus觸覺軟件是世界上第一套能讓設計師及雕刻家在電腦上利用觸覺的方式就能完成3D模型的建構(gòu)的系統(tǒng)。設計師可以隨心所欲并且快速地創(chuàng)造出自己想要的復雜模型,就像雕刻黏土一樣真實、生動,完全擺脫傳統(tǒng)3D軟件的束縛,將設計師的創(chuàng)意、靈感及想表達的意圖完美地呈現(xiàn)出來,讓產(chǎn)品設計有更大的突破。
Freeform Modeling Plus電腦雕刻筆完全擺脫了一般3D設計軟件的限制,設計師不需要繼續(xù)在復雜的電腦程序-數(shù)學方程式、鼠標與鍵盤指令、程序化的方法等阻礙下工作,系統(tǒng)提供了我們與真實世界互動的最基本方式——觸覺,你可以通過觸感,與您的模型進行直接和自然的互動。例如,一個像恐龍一樣復雜的三維數(shù)字模型,設計師30分鐘就可以解決問題,大大縮短了傳統(tǒng)3D設計軟件的制作周期,這樣,您將擁有更多的時間和精力投身于真正的挑戰(zhàn),將您更多的創(chuàng)意轉(zhuǎn)變?yōu)楦咂焚|(zhì)的產(chǎn)品或工藝作品
同時,它也將實體功能帶入了數(shù)字領域,這樣一來,您就可以通過一個自然、類比的互動過程獲得一個珍貴的數(shù)字化的三維模型。簡單、直接的觸覺互動;精確、細微的觸覺控制,這一切都讓你隨心所欲的將你的設計理念和美感賦予您充滿智慧和富有創(chuàng)意的精品之作,世界各地的設計家已漸漸開始發(fā)現(xiàn)FreeForm Modeling Plus系統(tǒng)在這些行業(yè)所能夠帶來的好處,從工業(yè)產(chǎn)品、玩具與游戲、禮品與鞋子,到消費電器、日用品,以及汽車內(nèi)部設計,無不受用無窮,使設計過程變的十分方便。
FreeForm Modeling Plus電腦雕刻筆模型制作:
● 以靈活簡便的功能取代令人頭疼的復雜電腦程序。
● 開啟計算機與設計師之間的設計理念的交流之門。
● 使用實體、類比介面來創(chuàng)建一個直觀、可調(diào)度的數(shù)字模型。
● 允許設計師獲得形態(tài)與功能的理想調(diào)和。
● 激勵探索與反復思考創(chuàng)建難以數(shù)字化描述的理想作品。
|